Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 28 min ago
Peer-reviewedCC BYEuropean journal of pain (London, England)

The α2‐Subunit Preferring GABA Positive Allosteric Modulator, N‐Desmethyl‐Clobazam in Peripheral Neuropathic Pain Patients: Results of a Phase IIa Randomised Placebo‐Controlled Ascending Dose Study

  • M. Besson1
  • A. Matthey1
  • Y. Daali1
  • A. Ramsahye1
  • C. Samer1
  • J. Desmeules2
  • F. Curtin1
  1. 1Geneva University Hospitals
  2. 2University of Geneva
Read full textPDFCite

Related

  1. Discovery of GluA3 preferring AMPA receptor positive allosteric modulator BRD3290
    C. Greaves, W. E. Martenis, S. D. Nelson +16
    bioRxivPreprintAll rights reservedFull textPharmacology & toxicologybioRxiv
  2. Efficacy and Safety of Crisugabalin for Inadequately Controlled Diabetic Peripheral Neuropathic Pain: A Randomized, Active‐Controlled, Phase 2 Trial
    Yaming Li, Fang Zhang, Wei Liu +9
    Diabetes, Obesity & MetabolismPeer-reviewedCC BY-NC-ND 4.0Full text1 citedPhysiologyPMC
  3. Effect of virtual reality on pain, anxiety and fear during peripheral venous catheterisation: a systematic review and meta-analysis of randomised controlled trials.
    Wenjuan Cao, Fei Wang, Lu Tang +5
    BMJ openPeer-reviewedCC BY-NCFull textObstetrics, gynaecology & paediatricsEurope PMCCrossref
  4. Ultrasound guidance versus near-infrared light versus the standard technique for first-attempt success of peripheral intravenous catheterisation in adults with difficult venous access in a medical imaging department (RÉUSSIR-VVP): protocol for a single-centre, three arms, randomised controlled trial
    Guillaume Davy, Florian Nassiri, Victor Dumas +3
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textGeneral medicineCrossref
  5. Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial
    Jérémy Guenezan, Nicolas Marjanovic, Bertrand Drugeon +11
    The Lancet Infectious DiseasesPeer-reviewedLicence not statedFull text64 citedGeneral biologyInfectious diseaseHAL

Cite

BibTeXRIS
BibTeX
@article{besson2026α2subunit,
  title = {{The α2‐Subunit Preferring GABA Positive Allosteric Modulator, N‐Desmethyl‐Clobazam in Peripheral Neuropathic Pain Patients: Results of a Phase IIa Randomised Placebo‐Controlled Ascending Dose Study}},
  author = {M. Besson and A. Matthey and Y. Daali and A. Ramsahye and C. Samer and J. Desmeules and F. Curtin},
  journal = {European journal of pain (London, England)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13674364},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - The α2‐Subunit Preferring GABA Positive Allosteric Modulator, N‐Desmethyl‐Clobazam in Peripheral Neuropathic Pain Patients: Results of a Phase IIa Randomised Placebo‐Controlled Ascending Dose Study
AU  - M. Besson
AU  - A. Matthey
AU  - Y. Daali
AU  - A. Ramsahye
AU  - C. Samer
AU  - J. Desmeules
AU  - F. Curtin
PY  - 2026
DA  - 2026/10/01
JO  - European journal of pain (London, England)
UR  - https://europepmc.org/article/PMC/PMC13674364
SN  - 1090-3801
SN  - 1532-2149
ER  -